High-resolution studies of self-assemblies of semifluorinated alkanes molecules F12H8 and F14H20 [FnHm = CF3(CF2)n(CH2)mCH3], and CdTe particles were performed with single-pass Kelvin force microscopy. Surface potential contrast, which is related to the strength and orientation of molecular dipoles, empowers the characterization of self-organized structures. Lamellar structures, ribbons and toroids of F14H20 and F12H8 were observed on graphite and the differences of surface potential were interpreted in terms orientation of -CH2-CF2- dipoles. A gradual sublimation of F12H8 molecules allowed a visualization of top and bottom molecular layers on the substrate. Prior to the sublimation a part of lamellae of the bottom layers was transformed into the ribbons. The surface potential data suggest that this transition proceeds with the reorientation of the molecular chains from the horizontal to vertical direction. Self-assembly of CdTe nanoparticles into nanowires was monitored upon drying on mica. The process is accompanied by drastic changes of surface potential. The formed nanowires exhibit strong positive surface potential that assumes a structural transition with a formation of strong dipole moment in these self-assemblies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1166/jnn.2010.2876 | DOI Listing |
ACS Sens
January 2025
Department of Physics, Umeå University, Umeå SE-901 87, Sweden.
Bacterial spores are highly resilient and capable of surviving extreme conditions, making them a persistent threat in contexts such as disease transmission, food safety, and bioterrorism. Their ability to withstand conventional sterilization methods necessitates rapid and accurate detection techniques to effectively mitigate the risks they present. In this study, we introduce a surface-enhanced Raman spectroscopy (SERS) approach for detecting spores by targeting calcium dipicolinate acid (CaDPA), a biomarker uniquely associated with bacterial spores.
View Article and Find Full Text PDFHepatology
January 2025
Genome Medical Science Project, National Center for Global Health and Medicine, Ichikawa, Japan.
Background Aims: Hepatitis B virus (HBV) leads to severe liver diseases, such as cirrhosis and hepatocellular carcinoma. Identification of host factors that regulate HBV replication can provide new therapeutic targets. The discovery of sodium taurocholate cotransporting polypeptide (NTCP) as an HBV entry receptor has enabled the establishment of hepatic cell lines for analyzing HBV infection and propagation.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
January 2025
PharmaEase Tech Limited, Sheung Wan, Hong Kong, China.
We develop a technology based on competitive adsorption between drug molecules and water, specifically designed to address the critical issue of poor drug solubility. By specially engineering silica nanosurfaces with ultrahigh densities of silanol, we significantly enhance their affinity for both drug molecules and water, with a notably greater increase in water affinity. Such surfaces can effectively adsorb a variety of drug molecules under dry conditions.
View Article and Find Full Text PDFDermatol Ther (Heidelb)
January 2025
Department of Clinical and Molecular Sciences-Dermatological Clinic, Università Politecnica Delle Marche, Ancona, Italy.
Introduction: Palmoplantar psoriasis (PPp) has a profound negative impact on patients' quality of life, and it represents a therapeutic challenge, as palms and soles are difficult to treat area. Although the efficacy profile of tildrakizumab has been well evaluated in the literature, data on its use for PPp are still limited. The objective of the study was to evaluate the efficacy and safety of tildrakizumab on moderate-to-severe plaque psoriasis with involvement of the palmoplantar area.
View Article and Find Full Text PDFEsophagus
January 2025
Department of Medical Oncology, National Taiwan University Cancer Center, 7 Chung-Shan South Road, Taipei, 10002, Taiwan.
Esophageal squamous cell carcinoma (ESCC) is a prevalent and highly lethal malignancy in Asia. Recent advancements in immune checkpoint inhibitors (ICIs) have markedly transformed the systemic therapy landscape for ESCC. Anti-PD-1-based combination with chemotherapy or with ipilimumab, an anti-CTLA-4 antibody, have been established as the new standard first-line treatments for patients with advanced ESCC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!